SCUBE3

signal peptide, CUB domain and EGF like domain containing 3

Basic information

Region (hg38): 6:35213956-35253079

Previous symbols: [ "CEGF3" ]

Links

ENSG00000146197NCBI:222663OMIM:614708HGNC:13655Uniprot:Q8IX30AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 2 (Strong), mode of inheritance: AR
  • short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 2 (Moderate), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomaliesARCardiovascularAmong other features, the condition can involve arrhythmias, and awareness can allow early diagnosis and managementAudiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dental; Musculoskeletal; Neurologic33308444

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SCUBE3 gene.

  • Short stature;Abnormal facial shape;Abnormality of the skeletal system;Abnormality of the dentition (5 variants)
  • Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 2 (4 variants)
  • Abnormal facial shape;Short stature;Abnormality of the skeletal system;Abnormality of the dentition (2 variants)
  • not provided (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SCUBE3 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
missense
2
clinvar
1
clinvar
57
clinvar
1
clinvar
3
clinvar
64
nonsense
3
clinvar
3
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
2
clinvar
2
splice region
1
1
non coding
1
clinvar
1
Total 7 1 58 1 4

Variants in SCUBE3

This is a list of pathogenic ClinVar variants found in the SCUBE3 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
6-35214425-T-G Inborn genetic diseases Uncertain significance (Apr 07, 2023)2512584
6-35214431-C-T Inborn genetic diseases Uncertain significance (Feb 06, 2024)3158795
6-35214477-C-T Inborn genetic diseases Uncertain significance (Jun 01, 2023)2554853
6-35227638-C-G Inborn genetic diseases Uncertain significance (Sep 28, 2022)2314349
6-35227640-C-T Inborn genetic diseases Uncertain significance (Dec 22, 2023)3158796
6-35227651-T-C Inborn genetic diseases Uncertain significance (Jan 30, 2024)3158799
6-35228616-G-A Inborn genetic diseases Uncertain significance (Oct 10, 2023)3158801
6-35228644-C-G Inborn genetic diseases Uncertain significance (Jan 10, 2022)2411817
6-35228696-C-G Abnormality of the dentition;Short stature;Abnormal facial shape;Abnormality of the skeletal system • Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 2 Pathogenic (Sep 01, 2020)981655
6-35228704-G-T Inborn genetic diseases Uncertain significance (Feb 12, 2024)3158806
6-35231773-T-G Inborn genetic diseases Uncertain significance (Aug 15, 2023)2603479
6-35231796-T-C Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 2 Uncertain significance (Aug 01, 2021)1679305
6-35231868-A-G Benign (Jul 18, 2018)716891
6-35232916-G-A Inborn genetic diseases Uncertain significance (Dec 19, 2022)2377024
6-35232919-T-C Inborn genetic diseases Uncertain significance (Jan 29, 2024)3158807
6-35232964-G-A Inborn genetic diseases Uncertain significance (Aug 15, 2023)2588530
6-35233200-G-A Abnormality of the dentition;Short stature;Abnormal facial shape;Abnormality of the skeletal system Pathogenic (Sep 01, 2020)981656
6-35233221-C-T Inborn genetic diseases Uncertain significance (Dec 14, 2021)2352024
6-35233280-A-G Benign (May 03, 2018)708924
6-35233306-G-C Uncertain significance (Mar 28, 2023)3342909
6-35237953-C-T Inborn genetic diseases Uncertain significance (Nov 08, 2022)2324754
6-35237988-A-C Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 2 Uncertain significance (-)2664229
6-35238017-AGGTAAGGACTTTGAGAGGACAGAAGCAGAGTGACCTTTGGTAAGGGGCTGAGGTTGGGACCAGAGATAGGGTGCCTATTAGGGGATGACACCTCCTCAACCTCCTTCTTATGAAGAACCCAGGACATAGCTAAGGGTTGTCTCCTATCTGCCTGTTTCATCTCAGTTCAAGGGACAGAGAAGTCCAGCCAGTTCCTTAGTGCCCCCTTCCCCTACCCCACCTTGTTTCCCTACTCTCATTCCTATCCCCCATGGGTCCCTAACCCTCTTAGTTAATGGACATGCGATTCACATTTGCTCCTGGGTCTGGAAGGATATTTGAGCCCTGACTGTGTGTGTGCATGAGGTCACAGGTGTGTTCCATAACCTTCTTACCCCACATTCCTCAGACCTTCCCAGTGGGCTCTGGGGAAATGATGTCTACCCCTCGAAAGGCTGTACTGGTCAAAGGGAGAGTAGGATACTAGTTAGGAGGACTGAAGCTGGGTTCAGATCCCAGCCCTGTCTCCTACTAGCTCTGTGATCCTGGACAAGTCACTTAATGTCTCTGTGCCTCAGTTTTCCATAGTGCTCGCCTCATACTGTGTTGTGATTAAAAGAGTGATTACATAAAAAGTACTTAGAACAGTGCTTGGCAAATGGAAACACTTTGTGTTAACTGTTATTACAGTATAGTTACCCACATTATGCATTCTGTTTCCCTTCCTTTTAATTAGCCAGGTCTGAGGGAGAATGGGGGGAAAGGGTGGAGGAAAAAGGCAGGGTAGCCATACTGAAAATGATGATTCATTAGGTCCATATCCCCTGGTCACAAGGAGTGGGGACGAGGAGGACTGGGCTCGTTCTTTGTGTCTTTTGGCCCAACAGCTGCGAGAGGAGGGGGGAGGCTAGGGCAGCAGGTCAGCCAGCCAGAGTTGAGAGGTTTCCTGCTGGGAAGAACTGTTGACAGGTATGCTAAGAGTGAAGTGAAAGGCTGCCCTCCCTGCCCCTTCCCCCAACCAGGGGTGAGTAGCCTGGGTCCTGTCTGCCACCAGCTTGGGGAACTTGACCTCAGGAAGGAAGCCATTCACCAGCCCCCCTTTCCCTTACTAGTGCTGAAAGCTGCCTCAGGCCTGAGTCTCTCCAGATCTCTCCCAGTCCAGCCCCTTGCCTGGCCCCCAGCCCTCCCCCATCAGCTACCCAGCCTCACTGGCTCTCCTGGAGGTCCTCCCTGCCTGGCCTCTTTCCCAGCTCCTCCTCCTCCCTAAAGGGCTGCCCGTTTTCAGTGAGTCCCTTTAGACCCTCCACCTCTCCTTGCCCCGCACCCCCCCAACCCCCCGTCCTGAGGGACAGGAAAGAGATAACCCTTACCCACCAACCTTTCAGGGAATGGCCATCAGCTGGAGACTAAGGGCTAGCCTGTTAGGTCAAATGCCCACCTGCCCCTCCTCTAGGTAATTCCCTGAGGGCCTGTTCCTAGTTTTGGTTCCAATTTGTCCCCTTATAAGAACACTCAATCCCAGAAGAGAGGGTGTTACTAATGGCCACAGATCCCCTGAACAGGGAAGAAACAGAGACAGGAAAGAGAGAGAGAGACAGGAAAGAGAAAGAGAAAGAGACAGAGAGAGATCAAGAAGAGGCAGGCCCAGGACTCCTTGATTTTTGCATGTCTCTGTCAGTGAGGGAGGGATCTTTCTCCTTGTTTGTTCTCAGCCTTTGATAGTATCTTTTATCCTGTTTTGTCCTCCTTCTTCAGATATAGATGAGTGCCGCTTAAACAACGGGGGCTGTGACCATATTTGCCGCAACACAGTGGGCAGCTTCGAATGCAGTTGCAAGAAAGGCTATAAGCTTCTCATCAATGAGAGGAACTGCCAG-A Abnormality of the dentition;Short stature;Abnormal facial shape;Abnormality of the skeletal system Pathogenic (Sep 01, 2020)981657
6-35239766-C-T Inborn genetic diseases Uncertain significance (Aug 17, 2022)2253810
6-35239774-C-A Inborn genetic diseases Uncertain significance (Jan 03, 2024)3158808

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SCUBE3protein_codingprotein_codingENST00000274938 2238667
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9990.0006141257280201257480.0000795
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.704256130.6930.00003716552
Missense in Polyphen147249.980.588042711
Synonymous2.271912350.8120.00001451895
Loss of Function5.80752.20.1340.00000289593

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002460.000242
Ashkenazi Jewish0.0003980.000397
East Asian0.0001090.000109
Finnish0.00009240.0000924
European (Non-Finnish)0.00004410.0000439
Middle Eastern0.0001090.000109
South Asian0.00006530.0000653
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Binds to TGFBR2 and activates TGFB signaling. In lung cancer cells, could serve as an endogenous autocrine and paracrine ligand of TGFBR2, which could regulate TGFBR2 signaling and hence modulate epithelial-mesenchymal transition and cancer progression. {ECO:0000269|PubMed:21441952}.;
Pathway
Extracellular matrix organization;Degradation of the extracellular matrix (Consensus)

Recessive Scores

pRec
0.0910

Intolerance Scores

loftool
0.0393
rvis_EVS
-0.22
rvis_percentile_EVS
37.66

Haploinsufficiency Scores

pHI
0.246
hipred
Y
hipred_score
0.765
ghis
0.531

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.357

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Scube3
Phenotype
limbs/digits/tail phenotype; hearing/vestibular/ear phenotype; skeleton phenotype; renal/urinary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; growth/size/body region phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); normal phenotype; craniofacial phenotype; homeostasis/metabolism phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan);

Gene ontology

Biological process
extracellular matrix disassembly;positive regulation of smoothened signaling pathway;protein homooligomerization;protein heterooligomerization
Cellular component
extracellular space;plasma membrane;cell surface
Molecular function
calcium ion binding;protein binding